The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 28th 2024
Using multiple physicians or pharmacists can result in a lack of coordinated care, missed medication interactions, and overlooked contraindications.
NACDS Notes Improvements and Remaining Problems in Defense Bill's TRICARE Approach
December 8th 2014As Congress continues consideration of the bipartisan conference agreement to the FY 2015 National Defense Authorization Act National Association of Chain Drug Stores, President and CEO Steven C. Anderson, IOM, CAE issued a statement.
Read More
World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017
December 8th 2014World TeamTennis, the innovative leader in professional team tennis competition, and Mylan, one of the world's leading pharmaceutical companies, today announced an extension of their title sponsorship agreement through 2017.
Read More
Cardinal Health Launches New Analytics Tool to Help Hospitals Improve Antibiotic Stewardship Efforts
December 8th 2014Cardinal Health today introduced a powerful new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends and identify significant opportunities to improve antibiotic stewardship efforts.
Read More
Survey: Consumers Lack Knowledge of Obamacare Tax Implications
December 8th 2014The upcoming tax season will be the first time Americans face penalties for not having health insurance, but a new survey suggests the public is still very much confused about their responsibilities and options.
Read More
Loeb Receives ASHP Board of Directors Award of Honor
December 8th 2014ASHP today recognized the work of the late Jerod M. Loeb, Ph.D., a tireless patient safety advocate, with the ASHP Board of Directors Award of Honor. Loeb's widow, Sherri, accepted the award during the opening session of ASHP's Midyear Clinical Meeting in Anaheim, CA. Dr. Loeb passed away in 2013 from metastatic prostate cancer.
Read More
Kienle Receives ASHP Award for Distinguished Practice Leadership
December 8th 2014ASHP today honored Patricia Clancy Kienle, R.Ph., M.P.A., FASHP, with its Board of Directors Award for Distinguished Leadership in Pharmacy Practice during the opening session of the association's 49th Midyear Clinical Meeting in Anaheim, CA.
Read More
Cold and Flu Meds Pose Risks For High Blood Pressure
December 8th 2014If you have high blood pressure and purchase an over-the-counter medication, you may be getting more than you bargained for. That's the word from experts who caution that some medications taken over the counter can have a negative impact on blood pressure. If patients are unknowingly taking medications that elevate blood pressure, it could undermine efforts to keep blood pressure in a safe range.
Read More
Mild Coronary Artery Disease Puts Diabetics at Cardiovascular Risk
December 8th 2014New study results dispute the belief that diabetic patients with mild or non-obstructive coronary artery disease have a lower risk of major adverse cardiovascular events and death than their counterparts with obstructive disease.
Read More
Astellas Announces End of License Agreement with Janssen to Develop and Commercialize ASP015K
December 7th 2014Astellas Pharma, Inc, announced that its license agreement with Janssen Biotech, Inc, to develop and commercialize ASP015K, Astellas' oral Janus Kinase inhibitor, will end effective January 15, 2015.
Read More
Researchers at the American Epilepsy Society meeting reported important strides in the understanding of epilepsy, including identification of new therapeutic targets in the brain, as discussed by Esther Krook-Magnuson, PhD, as well as improved understanding of the factors involved in sudden death of patients with epilepsy, and a greater recognition of the benefits of neurosurgery in patients with epilepsy.
Read More
Integrating New Antiepileptic Medications into Clinical Practice: Ezogabine and Eslicarbazepine
December 7th 2014Several new antiepileptic drugs have recently been approved in the United States. In a symposium at the American Epilepsy Society in Seattle, Washington, Professor Martin J. Brodie, MD, director of the epilepsy unit of the Western Infirmary in Glasgow, Scotland, discussed some considerations with ezogabine and eslicarbazepine.
Read More
Predicting Seizures Before They Happen, Using Novel Sensors, Biomarkers, and Big Data
December 7th 2014Mark Cook, MD, of the University of Melbourne, and Brian Litt, MD, of the Penn Epilepsy Center and the Center for Neuroengineering and Therapeutics at the University of Pennsylvania, discuss how new devices, big data, and massive online competitions are enabling prediction of seizures before they start.
Read More
16th Annual NACDS Foundation Dinner Raises $1.9 Million for Cutting-Edge Research Portfolio
December 7th 2014The National Association of Chain Drug Stores Foundation celebrated its 16th Annual Foundation Dinner last evening in New York City, New York. The dinner raised a record $1.9 million, which will continue to fuel the Foundation's patient-centered care research agenda, which was on full display during the gala event. Walgreen Co. and Duane Reade Inc. were the premier sponsors of last evening's event. More than 100 companies from a diverse range of industries sponsored the event.
Read More